Silence Therapeutics plc
SLNCF
$1.80
$0.2012.50%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.96M | -27.35M | -28.53M | 10.34M | -35.54M |
| Total Depreciation and Amortization | 156.00K | 148.00K | 138.00K | 149.80K | 151.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 848.00K | 9.92M | 5.59M | -11.36M | 12.69M |
| Change in Net Operating Assets | 9.06M | -4.50M | 10.49M | -26.76M | -2.90M |
| Cash from Operations | -10.89M | -21.78M | -12.31M | -27.62M | -25.61M |
| Capital Expenditure | -3.00K | -48.00K | -4.00K | -65.80K | -64.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.29M | -1.51M | -44.38M | 62.39M | -38.08M |
| Cash from Investing | 51.29M | -1.56M | -44.38M | 62.32M | -38.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 182.80K | -- |
| Issuance of Common Stock | 0.00 | 1.00K | 14.00K | -- | 7.97M |
| Repurchase of Common Stock | -- | -- | -- | -7.38M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 8.60M | -- |
| Cash from Financing | 0.00 | 1.00K | 14.00K | 1.40M | 7.97M |
| Foreign Exchange rate Adjustments | -106.00K | 198.00K | 232.00K | 6.53M | 268.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.29M | -23.15M | -56.44M | 42.62M | -55.51M |